C-Bond Systems Expands Exclusive Distribution Agreement with Quip Laboratories to Include Vimoba Tablets, Approved for Use Against SARS-CoV-2
February 17, 2022 08:30 ET
|
C-Bond Systems
HOUSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (“C-Bond” or “Company”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has expanded its exclusive...
C-Bond Systems’ EPA-Registered MB-10 Tablets Provide Effective Disinfection from SARS-CoV-2, the Virus that Causes COVID-19
December 03, 2020 08:30 ET
|
C-Bond Systems
HOUSTON, Dec. 03, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems’ (the “Company” or “C-Bond”) (OTC: CBNT) EPA-registered MB-10 Tablets provide an effective means of disinfection from a wide range of...
STERAMIST NOW ON EPA LIST N FOR EFFICACY AGAINST SARS CoV-2
March 18, 2020 09:30 ET
|
TOMI Environmental Solutions, Inc.
BEVERLY HILLS, Calif., March 18, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing...